MS and co-morbid autoimmunity
In my experience, the most common co-morbid autoimmune disease in people with MS, outside of thyroid disease post-alemtuzumab, is MS-associated…
MS vs NMO Attacks: What You Need To Know
Click Image to listen to this video…
Stuart Schlossman
The MS Views and News Learning Channel, Presents: THE 2023 MS SYMPOSIUM – watch these educational videos with MS Neurologists Boster, Rosenthal, Steingo and more
PLAYING 2023 MS Symposium (Part 1 of 5) – LIVING WELL with MS, Pain Management, Biomarkers and More 40:26…
Stuart Schlossman
High-Intensity Gait Training in an Individual With Neuromyelitis Optica and Research Recommendations for Individuals With Multiple Sclerosis
Abstract Background: Neuromyelitis optica (NMO), similar to multiple sclerosis (MS), is an autoimmune disorder affecting the central nervous system.…
Stuart Schlossman
Autonomic Symptom Burden and Decreased Quality of Life Among Patients With MS and NMOSD
Researchers in Serbia identified link between autonomic symptom burden and quality of life. Recently published findings in the journal Multiple…
Stuart Schlossman
Why Disability Strikes People With MS
In the past multiple sclerosis (MS) was thought to primarily affect whites. However, studies have shown a higher incidence…
Stuart Schlossman
Genentech to Present New Key Clinical and Real-world Data at ECTRIMS-ACTRIMS 2023 Showcasing Strength of Long-term Outcomes in MS and NMOSD
Late-breaking results from Phase III trial of Ocrevus (ocrelizumab) subcutaneous injection and Phase II trial of BTK inhibitor fenebrutinib in…
Stuart Schlossman
Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders
Abstract Objective: To evaluate clinical features among patients with neuromyelitis optica spectrum disorders (NMOSD) who have myelin oligodendrocyte glycoprotein…
Stuart Schlossman
Patients suffering from neuro-inflammatory diseases such as multiple sclerosis (MS) and neuromyelitis optica spectrum disorders (NMOSD) remain vulnerable to COVID-19.
Influence of Disease Modifying Treatment, Severe Acute Respiratory Syndrome Coronavirus 2 Variants and Vaccination on Coronavirus Disease 2019 Risk and…
Stuart Schlossman
COVID-19 infection after SARS-CoV-2 mRNA vaccination in Multiple Sclerosis, AQP4-antibody NMOSD and MOGAD patients during the Omicron subvariant BA.1/2 wave in Singapore
Tianrong Yeo 1 2 3, Rachel Wan En Siew 4, Muhammad Yaaseen Gulam 4, Janis Siew Noi Tye 4, Amelia…
Stuart Schlossman
